|
|
| 17 Dec 2025 | 13:12 IST |
|
Bajaj Finserv Healthcare Fund - Regular (IDCW) |
|
|
|
|
|
|
|
| NAV Details |
| NAV Date : |
16-Dec-25 |
| NAV [Rs]: |
9.61 |
| Buy/Resale Price [Rs] : |
0.00 |
| Sell/Repurchase Price [Rs] : |
0.00 |
| Max Entry Load % : |
0.00 |
| Max Exit Load % : |
0.00 |
|
|
|
|
|
|
|
|
| Quantum of Dividend % |
NA |
NA |
| Date |
NA |
NA |
|
|
|
|
|
|
| Tax benefits : |
|
| Min. Investment(Rs.) : |
500 |
| Increm.Investment(Rs.) : |
100 |
|
|
|
|
|
| Statistical Ratios |
What
is Beta ?
Beta is a measure of the volatility of the portfolio to that of the index. In
simple words it shows the movement of the portfolio in comparison. The Higher
the Beta, higher the volatility of the scheme to the index. If its greater
than1 , then the portfolio is highly volatile to the movemnts in the index. If
the beta is lesser than 1 , then scheme is less volatile to the index and beta
which is close to 1 implies that the scheme is closely following the index.
|
| 1.1143 |
4.7922 |
-0.3714 |
-12.0121 |
-0.0232 |
|
|
|
|
Divi's Lab.
|
8.41
|
|
Sun Pharma.Inds.
|
8.24
|
|
Apollo Hospitals
|
5.93
|
|
Aurobindo Pharma
|
5.54
|
|
Cipla
|
5.06
|
|
Piramal Pharma
|
4.40
|
|
Neuland Labs.
|
4.26
|
|
Biocon
|
4.00
|
|
Emcure Pharma
|
3.43
|
|
Fortis Health.
|
3.26
|
|
Rubicon Research
|
2.47
|
|
Lupin
|
2.23
|
|
Ipca Labs.
|
2.17
|
|
Glenmark Pharma.
|
2.05
|
|
Pfizer
|
1.96
|
|
Shaily Engineer.
|
1.91
|
|
Sanofi Consumer
|
1.91
|
|
Vijaya Diagnost.
|
1.82
|
|
Zydus Wellness
|
1.75
|
|
Godrej Consumer
|
1.69
|
|
Dr Lal Pathlabs
|
1.59
|
|
Glaxosmi. Pharma
|
1.59
|
|
Abbott India
|
1.54
|
|
Medi Assist Ser.
|
1.41
|
|
Medplus Health
|
1.23
|
|
Max Healthcare
|
1.20
|
|
Rainbow Child.
|
1.18
|
|
Hind. Unilever
|
1.14
|
|
Torrent Pharma.
|
1.13
|
|
Jubilant Pharmo
|
1.13
|
|
Alembic Pharma
|
1.07
|
|
Syngene Intl.
|
1.06
|
|
Tata Consumer
|
1.04
|
|
Emami
|
1.02
|
|
Mankind Pharma
|
0.97
|
|
Astrazeneca Phar
|
0.87
|
|
Eternal Ltd
|
0.78
|
|
Marico
|
0.67
|
|
C C I
|
4.34
|
|
Net CA & Others
|
-1.08
|
|
Bajaj Finserv Money Market Fund - Direct (G)
|
1.49
|
|
Aurobindo Pharma
|
2.14
|
|
|
|
|
|
|
Asset Allocation
|
|
|
|
 |
|